NEW YORK, NY – Moody’s has downgraded the U.S. sovereign credit rating, citing mounting concerns over the nation’s ballooning $36 trillion debt. The downgrade, announced on May 16 ...

On June 3, Stifel Nicolaus analyst Stephen Willey maintained a Buy rating on Nurix Therapeutics, Inc. (NASDAQ:NRIX) with a price target of $35. The reiteration comes after Sanofi exercised its ...

President Donald Trump's approval ratings held steady early on in his second term, despite the chaotic start that included mass firings of government workers, the ongoing tariff trade wars and ...

The brokerage set a “buy” rating and a $38.00 price target on the stock. Stifel Nicolaus’ target price points to a potential upside of 36.25% from the stock’s current price. A number of ...